.Avidity Biosciences amazed capitalists with phase 1/2 data in Duchenne muscle dystrophy (DMD) Frida...
.Actinogen Medical's cortisol blocker has actually missed the major endpoint of a phase 2 research i...
.Antibody-drug conjugates (ADCs) have been at the facility of several a billion-dollar biobuck licen...
.Resource supervisor TPG, which has actually sustained biotechs like Sionna Therapeutics and Santa A...
.Merck & Co.'s TIGIT program has gone through another obstacle. Months after shuttering a period ...
.After a year determined through pipe cuts, the departure of its own chief executive officer as well...
.Cullinan Rehab was excited good enough along with Port BioMed's bispecific immune system reactor th...
.Within this week's episode of "The Best Line," we are actually diving in to Fierce Biotech's yearly...
.The confetti is actually still soaring coming from Eli Lilly's event celebrating the approval of Al...
.Welcome to this week's Chutes & Ladders, our roundup of notable leadership hirings, shootings as...